BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30809284)

  • 1. Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy.
    Jia Q; Yang F; Huang W; Zhang Y; Bao B; Li K; Wei F; Zhang C; Jia H
    Theranostics; 2019; 9(2):424-435. PubMed ID: 30809284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
    Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient extravasation of tumor-repopulating cells depends on cell deformability.
    Chen J; Zhou W; Jia Q; Chen J; Zhang S; Yao W; Wei F; Zhang Y; Yang F; Huang W; Zhang Y; Zhang H; Zhang Y; Huang B; Zhang Z; Jia H; Wang N
    Sci Rep; 2016 Jan; 6():19304. PubMed ID: 26787224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression.
    Tan Y; Tajik A; Chen J; Jia Q; Chowdhury F; Wang L; Chen J; Zhang S; Hong Y; Yi H; Wu DC; Zhang Y; Wei F; Poh YC; Seong J; Singh R; Lin LJ; Doğanay S; Li Y; Jia H; Ha T; Wang Y; Huang B; Wang N
    Nat Commun; 2014 Aug; 5():4619. PubMed ID: 25099074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft matrices downregulate FAK activity to promote growth of tumor-repopulating cells.
    Tan Y; Wood AR; Jia Q; Zhou W; Luo J; Yang F; Chen J; Chen J; Sun J; Seong J; Tajik A; Singh R; Wang N
    Biochem Biophys Res Commun; 2017 Jan; 483(1):456-462. PubMed ID: 28007596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3/p53 pathway activation disrupts IFN-β-induced dormancy in tumor-repopulating cells.
    Liu Y; Lv J; Liu J; Liang X; Jin X; Xie J; Zhang L; Chen D; Fiskesund R; Tang K; Ma J; Zhang H; Dong W; Mo S; Zhang T; Cheng F; Zhou Y; Jia Q; Zhu B; Kong Y; Guo J; Zhang H; Hu ZW; Cao X; Qin FX; Huang B
    J Clin Invest; 2018 Mar; 128(3):1057-1073. PubMed ID: 29431732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of YAP-dependent Nupr1 promotes tumor-repopulating cell growth in soft matrices.
    Jia Q; Zhou W; Yao W; Yang F; Zhang S; Singh R; Chen J; Chen JJ; Zhang Y; Wei F; Zhang Y; Jia H; Wang N
    Oncogenesis; 2016 Apr; 5(4):e220. PubMed ID: 27089143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin Stiffness Mediates Dormancy of Tumor-Repopulating Cells via a Cdc42-Driven Tet2 Epigenetic Program.
    Liu Y; Lv J; Liang X; Yin X; Zhang L; Chen D; Jin X; Fiskesund R; Tang K; Ma J; Zhang H; Dong W; Mo S; Zhang T; Cheng F; Zhou Y; Xie J; Wang N; Huang B
    Cancer Res; 2018 Jul; 78(14):3926-3937. PubMed ID: 29764867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cancer stem cell like cells by a synthetic retinoid.
    Chen J; Cao X; An Q; Zhang Y; Li K; Yao W; Shi F; Pan Y; Jia Q; Zhou W; Yang F; Wei F; Wang N; Yu B
    Nat Commun; 2018 Apr; 9(1):1406. PubMed ID: 29643385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors.
    Li Y; Luo S; Ma R; Liu J; Xu P; Zhang H; Tang K; Ma J; Zhang Y; Liang X; Sun Y; Ji T; Wang N; Huang B
    Cancer Res; 2015 Apr; 75(7):1191-6. PubMed ID: 25712344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
    Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
    Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of
    Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL
    Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory networks in mechanotransduction reveal key genes in promoting cancer cell stemness and proliferation.
    Huang W; Hu H; Zhang Q; Wu X; Wei F; Yang F; Gan L; Wang N; Yang X; Guo AY
    Oncogene; 2019 Oct; 38(42):6818-6834. PubMed ID: 31406247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
    Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
    Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of very small cancer stem cells expressing hallmarks of pluripotency in B16F10 melanoma cells and their reoccurrence in B16F10-derived clones.
    Dias Câmara DA; Luiz de Sá Junior P; Alexandre de Azevedo R; Figueiredo CR; Araldi RP; Levy D; Madeiro de Souza D; Kerkis I
    Exp Cell Res; 2020 Jun; 391(2):111938. PubMed ID: 32278688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COL2A1 Is a Novel Biomarker of Melanoma Tumor Repopulating Cells.
    Talluri B; Amar K; Saul M; Shireen T; Konjufca V; Ma J; Ha T; Chowdhury F
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32962144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor dormancy: long-term survival in a hostile environment.
    Quesnel B
    Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma.
    Ravindran Menon D; Luo Y; Arcaroli JJ; Liu S; KrishnanKutty LN; Osborne DG; Li Y; Samson JM; Bagby S; Tan AC; Robinson WA; Messersmith WA; Fujita M
    Cancer Res; 2018 Dec; 78(23):6561-6574. PubMed ID: 30297536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway.
    Zhang X; Shao J; Li X; Cui L; Tan Z
    Oncol Rep; 2019 Feb; 41(2):1067-1074. PubMed ID: 30483804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.